Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Sensi.AI has introduced its Agentic Operating System, a unified platform that integrates care, operations, and growth for home care agencies. The system uses audio AI and predictive analytics to identify risks, automate tasks, and improve efficiency across caregiving networks.
XtalPi has entered a strategic partnership with an international biopharmaceutical company to develop oral small molecule therapeutics targeting a GPCR receptor, with a potential deal value exceeding $400 million.
qBotica and Atolio have announced a partnership to integrate Atolio’s enterprise AI search into qBotica’s automation services, enabling secure access to organizational knowledge for regulated industries.
Huxley Medical has added SANSA GO, a point of care enrollment model, and a new cardiovascular risk marker called hypoxic burden to its SANSA diagnostic platform. The updates expand the system's use for sleep apnea and cardiac monitoring.
Sky Labs presented its CART BP Pro cuffless blood pressure monitoring device at major European medical conferences, following its CE-MDR certification and growing clinical adoption in South Korea.
XFERALL has introduced the InTake Suite powered by aiXcel, a new tool designed to speed up behavioral health patient transfers and improve coordination across care facilities.
Aignostics has partnered with the Pancreatic Cancer Action Network to provide AI spatial profiling data for one of the largest pancreatic cancer datasets to date, making outputs freely available to researchers through PanCAN's SPARK platform.
UC Davis has received a $420,500 donation from the Susan and Charles Berghoff Foundation, with additional support from William Ballhaus and Darrin Mollett, to fund AggieBrain, an AI initiative that advances digital neuropathology research for dementia.
PartsSource has acquired SkillNet, a workforce intelligence platform for healthcare technology management, expanding its Enterprise Clinical Technology platform to include workforce readiness and training capabilities.
Cambridge-based Ambitious Bio has emerged from stealth, introducing a new approach to generating large-scale biological datasets designed for AI model training and disease research.
UCB is consolidating its global pharmacovigilance operations using Veeva Safety Suite to improve efficiency, standardize workflows, and enhance data management across its safety processes.
SciBase and Castle Biosciences have enrolled the first patient in a clinical study evaluating the use of electrical impedance spectroscopy to predict flare-ups in atopic dermatitis.
Photocure and Artera have launched a joint research initiative to evaluate the ArteraAI Bladder Test using data from Photocure’s blue light cystoscopy registry, aiming to improve diagnostic precision for bladder cancer.
Visage Imaging will highlight its AI optimized One Platform and the latest version of Visage 7 at the SIIM 2026 annual meeting in Pittsburgh, featuring new reporting and digital pathology capabilities.
FinThrive has introduced Denials Prevention Manager, an AI solution that predicts and prevents claim denials before submission by analyzing historical claims data and payer behavior.
Careviso has expanded its national physician and provider network to more than 460,000 enrollments, with plans to exceed 500,000 by the end of 2026. The company also introduced new enhancements to its seeQer platform to improve prior authorization efficiency.
The Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe) has introduced the first digital measures set designed for common mental health disorders. The release provides standardized tools for researchers, clinicians, and developers to assess treatment effects and patient outcomes using sensor-based data.
Fullspan Health has launched Healthline AI, a conversational health agent that provides medically reviewed information and guidance to consumers on Healthline.com. The tool features clinical guardrails, privacy protections, and triage protocols to help users make informed health decisions.
Insilica CEO Dr. Thomas Luechtefeld has co-authored a new framework called Evidence-based AI, introducing rigorous standards for AI systems in toxicology.
TFC Taipei Fertility Center in Taiwan has introduced an AI-based embryo assessment model that increases the accuracy of identifying chromosomally normal embryos by up to 24 percent, according to a press release. The system, iDAScore v2.0, analyzes time-lapse imaging and data from embryo development to support clinical decisions in IVF treatment.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
